相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vascular Normalization by Loss of Siah2 Results in Increased Chemotherapeutic Efficacy
Christina S. F. Wong et al.
CANCER RESEARCH (2012)
Time-Dependent Stabilization of Hypoxia Inducible Factor-1α by Different Intracellular Sources of Reactive Oxygen Species
Maura Calvani et al.
PLOS ONE (2012)
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy
Gregg L. Semenza
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Multihistology, Target-Driven Pilot Trial of Oral Topotecan as an Inhibitor of Hypoxia-Inducible Factor-1α in Advanced Solid Tumors
Shivaani Kummar et al.
CLINICAL CANCER RESEARCH (2011)
Hypoxia-mediated drug resistance: Novel insights on the functional interaction of HIFs and cell death pathways
Nadine Rohwer et al.
DRUG RESISTANCE UPDATES (2011)
Vitamin E and the Risk of Prostate Cancer The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
Eric A. Klein et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis
Xin Lu et al.
CLINICAL CANCER RESEARCH (2010)
Hypoxia-Inducible Factors and the Response to Hypoxic Stress
Amar J. Majmundar et al.
MOLECULAR CELL (2010)
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
G. L. Semenza
ONCOGENE (2010)
ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67
Vilppu J. Tuominen et al.
BREAST CANCER RESEARCH (2010)
Inhibition of Siah ubiquitin ligase function
A. Moller et al.
ONCOGENE (2009)
被撤回的出版物: Anthracycline chemotherapy inhibits HIF-1 transcriptional activity and tumor-induced mobilization of circulating angiogenic cells (Retracted article. See vol. 119, 2022)
KangAe Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structural Adaptation and Heterogeneity of Normal and Tumor Microvascular Networks
Axel R. Pries et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
HIF-dependent antitumorigenic effect of antioxidants in vivo
Ping Gao et al.
CANCER CELL (2007)
Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment
Benjamin J. Moeller et al.
CANCER AND METASTASIS REVIEWS (2007)
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1α
David Z. Qian et al.
CANCER RESEARCH (2006)
Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer
GV Thomas et al.
NATURE MEDICINE (2006)
Interventions for paracetamol (acetaminophen) overdose
J. Brok et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
N-acetylcysteine - passe-partout or much ado about nothing?
ML Aitio
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer
M Liu et al.
CANCER RESEARCH (2005)
The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression
RB Luwor et al.
ONCOGENE (2005)
Normalization of tumor vasculature: An emerging concept in antiangiogenic therapy
RK Jain
SCIENCE (2005)
N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer
A Agarwal et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Antioxidant agents are effective in inducing lymphocyte progression through cell cycle in advanced cancer patients:: assessment of the most important laboratory indexes of cachexia and oxidative stress
G Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2003)
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation
F Sjöö et al.
BONE MARROW TRANSPLANTATION (2003)
Regulation of angiogenesis by hypoxia: role of the HIF system
CW Pugh et al.
NATURE MEDICINE (2003)
Molecular mechanisms of N-acetylcysteine actions
M Zafarullah et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1α-degradative pathway
JS Isaacs et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Hypoxia - A key regulatory factor in tumour growth
AL Harris
NATURE REVIEWS CANCER (2002)
A conserved family of prolyl-4-hydroxylases that modify HIF
RK Bruick et al.
SCIENCE (2001)
C-elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
ACR Epstein et al.
CELL (2001)
Select: The next prostate cancer prevention trial
EA Klein et al.
JOURNAL OF UROLOGY (2001)
HIFα targeted for VHL-mediated destruction by proline hydroxylation:: Implications for O2 sensing
M Ivan et al.
SCIENCE (2001)
Targeting of HIF-α to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation
P Jaakkola et al.
SCIENCE (2001)
N-acetylcysteine reduces respiratory burst but augments neutrophil phagocytosis in intensive care unit patients
AR Heller et al.
CRITICAL CARE MEDICINE (2001)
Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens
C Nathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer
N van Zandwijk et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
